Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
PSTV
Plus Therapeutics
Last Price:
1.19
Seasonality Move:
7.07%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight buying pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.23 | Sell |
20-day SMA: | 1.3 | Sell |
50-day SMA: | 1.39 | Sell |
200-day SMA: | 1.71 | Sell |
8-day EMA: | 1.23 | Sell |
20-day EMA: | 1.28 | Sell |
50-day EMA: | 1.37 | Sell |
200-day EMA: | 1.74 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 40.74 | Sell |
Chaikin Money Flow: | -12173 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Plus Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.19 while PSTV 8-day simple moving average is 1.23, which is a Sell signal.
- The stock price of PSTV is 1.19 while Plus Therapeutics 20-day SMA is 1.30, which makes it a Sell.
- Plus Therapeutics 50-day simple moving average is 1.39 while PSTV share price is 1.19, making it a Sell technically.
- PSTV stock price is 1.19 and Plus Therapeutics 200-day simple moving average is 1.71, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.19. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
7.02M
Price in USD:
1.19
Share Volume:
15.22K
Plus Therapeutics 52-Week Range
52-Week High:
2.67
52-Week Low:
1.15
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.19 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.19 while PSTV 8-day exponential moving average is 1.23, which is a Sell signal.
- The stock price of PSTV is 1.19 while Plus Therapeutics 20-day EMA is 1.28, which makes it a Sell.
- Plus Therapeutics 50-day exponential moving average is 1.37 while PSTV share price is 1.19, making it a Sell technically.
- PSTV stock price is 1.19 and Plus Therapeutics 200-day simple moving average is 1.74, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Plus Therapeutics is a Sell
- Plus Therapeutics Relative Strength Index (RSI) is 40.74, which suggest Plus Therapeutics is oversold
- The Bollinger Bands (25) for Plus Therapeutics is ( - ), which suggest Plus Therapeutics is a Buy
- The Bollinger Bands (100) for Plus Therapeutics is ( - ), which suggest Plus Therapeutics is a Buy
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.